Literature DB >> 15661320

T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients.

Yong-Ku Kim1, Aye-Mu Myint, Bun-Hee Lee, Chang-Su Han, Seung-Whan Lee, Brian E Leonard, Harry W M Steinbusch.   

Abstract

It has been reported that the balance between T-helper type 1 (Th1) cytokines and T-helper type 2 (Th2) cytokines plays a role in psychiatric disorders such as bipolar disorder. The T-helper type 3 (Th3) cytokine, which transforming growth factor beta-1 (TGF-beta1), has been shown to modulate the production of Th1 and Th2 cytokines. However, the role of TGF-beta1 in bipolar disorder has not yet been explored. A total of 70 manic patients with bipolar disorder and 96 normal controls was recruited. The plasma levels of IFN-gamma, IL-4, and TGF-beta1 were studied at the time of admission and 8 weeks after mood stabilizer treatment. The detection rate and plasma concentrations of IFN-gamma and IL-4 and the IFN-gamma/TGF-beta1 and IL-4/TGF-beta1 ratios were significantly higher in patients than in controls, while the TGF-beta1 level was significantly lower. The TGF-beta1 level increased significantly after treatment and the IFN-gamma/TGF-beta1 and IL-4/TGF-beta1 ratios returned to control values. TGF-beta1 may play a role in the pathophysiology of bipolar disorder through the action of TGF-beta1 in modulating the IL-4/TGF-beta1 ratio.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15661320     DOI: 10.1016/j.psychres.2004.08.005

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  23 in total

1.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

2.  Proinflammatory Cytokines, Mood, and Sleep in Interepisode Bipolar Disorder and Insomnia: A Pilot Study With Implications for Psychosocial Interventions.

Authors:  Michael R Dolsen; Adriane M Soehner; Allison G Harvey
Journal:  Psychosom Med       Date:  2018-01       Impact factor: 4.312

Review 3.  Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.

Authors:  Joanna K Soczynska; Sidney H Kennedy; Hanna O Woldeyohannes; Samantha S Liauw; Mohammad Alsuwaidan; Christina Y Yim; Roger S McIntyre
Journal:  Neuromolecular Med       Date:  2010-12-17       Impact factor: 3.843

4.  Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.

Authors:  Tatiana Barichello; Vijayasree Vayalanellore Giridharan; Gursimrat Bhatti; Pavani Sayana; Tejaswini Doifode; Danielle Macedo; Joao Quevedo
Journal:  Curr Top Behav Neurosci       Date:  2021

5.  Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication.

Authors:  Robert D Oades; Maria R Dauvermann; Benno G Schimmelmann; Markus J Schwarz; Aye-Mu Myint
Journal:  Behav Brain Funct       Date:  2010-05-28       Impact factor: 3.759

Review 6.  The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.

Authors:  Michael Maes; Raz Yirmyia; Jens Noraberg; Stefan Brene; Joe Hibbeln; Giulia Perini; Marta Kubera; Petr Bob; Bernard Lerer; Mario Maj
Journal:  Metab Brain Dis       Date:  2008-12-16       Impact factor: 3.584

7.  Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity.

Authors:  P S Chen; C-C Wang; C D Bortner; G-S Peng; X Wu; H Pang; R-B Lu; P-W Gean; D-M Chuang; J-S Hong
Journal:  Neuroscience       Date:  2007-07-28       Impact factor: 3.590

8.  A pilot study investigating tumor necrosis factor-α as a potential intervening variable of atypical antipsychotic-associated metabolic syndrome in bipolar disorder.

Authors:  Alan R Prossin; Steven S Zalcman; Simon J Evans; McInnis G McInnis; Vicki L Ellingrod
Journal:  Ther Drug Monit       Date:  2013-04       Impact factor: 3.681

9.  Inflammatory markers among adolescents and young adults with bipolar spectrum disorders.

Authors:  Benjamin I Goldstein; Francis Lotrich; David A Axelson; Mary Kay Gill; Heather Hower; Tina R Goldstein; Jieyu Fan; Shirley Yen; Rasim Diler; Daniel Dickstein; Michael A Strober; Satish Iyengar; Neal D Ryan; Martin B Keller; Boris Birmaher
Journal:  J Clin Psychiatry       Date:  2015-11       Impact factor: 4.384

10.  Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders.

Authors:  David J Miklowitz; Larissa C Portnoff; Casey C Armstrong; Danielle Keenan-Miller; Elizabeth C Breen; Keely A Muscatell; Naomi I Eisenberger; Michael R Irwin
Journal:  Psychiatry Res       Date:  2016-05-07       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.